Tolvaptan

protein kinase D1 ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34486176 Pre-clinical evaluation of dual targeting of the GPCRs CaSR and V2R as therapeutic strategy for autosomal dominant polycystic kidney disease. 2021 Oct 1
2 28194574 Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease. 2017 May 1